The European Union announced on Wednesday the creation, for 540 million euros, of a stock of medicines and equipment intended to deal with nuclear, bacteriological and chemical emergencies, in a context of growing fear concerning the war of Russia in Ukraine.
Read alsoUkraine: how Russia could deploy a nuclear arsenal in Belarus
The European Commission, the executive of the 27-nation bloc, said the stockpile consists of "
vaccines
", "
equipment and medicine
" to treat patients injured during chemical, biological, radiological and nuclear attacks.
“Equipment intended for chemical, biological or nuclear emergencies”
The first step, according to the EU, will be to obtain "
potassium iodide tablets which can be used to protect people from the harmful effects of radiation
".
Three million iodine tablets have already been delivered to Ukraine, with the help of France and Spain, the Commission added.
"
We are taking concrete measures to better prepare Europe for potential threats
", with "
equipment intended for chemical, biological or nuclear emergencies
", declared the European Commissioner for Crisis Response, Janez Lenarcic.
Read also War in Ukraine: what is the “deterrent force” put on alert by Russia?
Since the start of the Russian invasion of Ukraine on February 24, many observers have raised the risk of the use of nuclear or chemical weapons in the conflict.
Westerners have warned that Moscow may use chemical weapons in the face of fierce resistance from the Ukrainians, who have blocked the Russian advance.
The fighting in Ukraine has also raised fears about the safety of nuclear facilities, such as Chernobyl, site of the worst nuclear accident in history in 1986, and Zaporozhye, Europe's largest power plant.
Russia has also placed its nuclear forces on high alert after warning Westerners not to intervene militarily to help Ukraine.